Comfort for the Afflicted

Erik Greb PharmTech editorResearchers and doctors continue to sound warnings about the rise in the number of cases of diabetes, which is closely linked to the increasing proportion of overweight individuals. After a period of decline, the rate of new HIV infections is increasing, reminding us of the gravity of that threat to world health. And the debate about whether cell phones cause cancer has been revived by unsettling new studies.

When we remember that Big Pharma’s pipelines are still generally weak, these troubling facts seem more disturbing. The picture is not entirely black, though. Researchers are hopeful about treatments for at least one medical condition. Read more »

Roche Ends HIV Reseach Program

Alexis Brekke Pellek PharmTech editorWhen I was in school, HIV/AIDS education was part of the health curriculum. I sat with my middle-, and then, high-school classmates and we learned about AIDS prevention, wore red ribbons, watched the made-for-TV movie The Ryan White Story, and attended school-wide AIDS awareness presentations by people living with HIV. All the time knowing scientists were hard at work finding a cure. Read more »

Vaccine Makers Prepare for Challenges Old and New

Maribel Rios PharmTech editorEarlier this month, the University of the Sciences in Philadelphia sponsored “The Future of Vaccines,” a symposium attended by experts in academia, government, and industry. During the meeting, these experts agreed that although vaccines hold a vital role in the future of public healthcare, there continue to be several major obstacles that must be overcome if the field is to progress. In their opinion, these challeges include access, inconsistent funding, public misperceptions, and scientific roadblocks. Read more »

« Previous Page